Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis

Whether 2(nd)-line-chemotherapy (2LCTX) + best-supportive-care (BSC) benefits patients with advanced biliary tract cancer (aBTC) more than BSC alone is unclear. We therefore conducted a propensity-score-based comparative effectiveness analysis of overall survival (OS) outcomes in 80 patients with me...

Descripción completa

Detalles Bibliográficos
Autores principales: Moik, Florian, Riedl, Jakob M., Winder, Thomas, Terbuch, Angelika, Rossmann, Christopher H., Szkandera, Joanna, Bauernhofer, Thomas, Kasparek, Anne-Katrin, Schaberl-Moser, Renate, Reicher, Andreas, Prinz, Felix, Pichler, Martin, Stöger, Herbert, Stotz, Michael, Gerger, Armin, Posch, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447553/
https://www.ncbi.nlm.nih.gov/pubmed/30944390
http://dx.doi.org/10.1038/s41598-019-42069-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447553/
https://www.ncbi.nlm.nih.gov/pubmed/30944390
http://dx.doi.org/10.1038/s41598-019-42069-1

Ejemplares similares